Merck’s COVID pill loses its lustre: what that means for the pandemic
Nature, Published online: 13 December 2021; doi:10.1038/d41586-021-03667-0
Molnupiravir was initially heralded by public-health officials as a game-changer for COVID-19, but full clinical-trial data showed lower-than-expected efficacy.
Comments
Post a Comment